Keywords
Last Name
Institution

Carmen Argmann

TitleASSISTANT PROFESSOR
InstitutionMount Sinai
DepartmentGenetics and Genomic Sciences
Address

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Houten SM, Herrema H, Te Brinke H, Denis S, Ruiter JP, van Dijk TH, Argmann CA, Ottenhoff R, Müller M, Groen AK, Kuipers F, Reijngoud DJ, Wanders RJ. Impaired amino acid metabolism contributes to fasting-induced hypoglycemia in fatty acid oxidation defects. Hum Mol Genet. 2013 Dec 20; 22(25):5249-61.
      View in: PubMed
    2. Houten SM, Denis S, Argmann CA, Jia Y, Ferdinandusse S, Reddy JK, Wanders RJ. Peroxisomal L-bifunctional enzyme (Ehhadh) is essential for the production of medium-chain dicarboxylic acids. J Lipid Res. 2012 Jul; 53(7):1296-303.
      View in: PubMed
    3. Houten SM, Argmann CA. New driver for lipid synthesis. Cell. 2011 Nov 11; 147(4):719-21.
      View in: PubMed
    4. Houtkooper RH, Argmann C, Houten SM, Cantó C, Jeninga EH, Andreux PA, Thomas C, Doenlen R, Schoonjans K, Auwerx J. The metabolic footprint of aging in mice. Sci Rep. 2011; 1:134.
      View in: PubMed
    5. Argmann C, Dobrin R, Heikkinen S, Auburtin A, Pouilly L, Cock TA, Koutnikova H, Zhu J, Schadt EE, Auwerx J. Ppargamma2 is a key driver of longevity in the mouse. PLoS Genet. 2009 Dec; 5(12):e1000752.
      View in: PubMed
    6. Tu Z, Argmann C, Wong KK, Mitnaul LJ, Edwards S, Sach IC, Zhu J, Schadt EE. Integrating siRNA and protein-protein interaction data to identify an expanded insulin signaling network. Genome Res. 2009 Jun; 19(6):1057-67.
      View in: PubMed
    7. Heikkinen S, Argmann C, Feige JN, Koutnikova H, Champy MF, Dali-Youcef N, Schadt EE, Laakso M, Auwerx J. The Pro12Ala PPARgamma2 variant determines metabolism at the gene-environment interface. Cell Metab. 2009 Jan 7; 9(1):88-98.
      View in: PubMed
    8. Keller MP, Choi Y, Wang P, Davis DB, Rabaglia ME, Oler AT, Stapleton DS, Argmann C, Schueler KL, Edwards S, Steinberg HA, Chaibub Neto E, Kleinhanz R, Turner S, Hellerstein MK, Schadt EE, Yandell BS, Kendziorski C, Attie AD. A gene expression network model of type 2 diabetes links cell cycle regulation in islets with diabetes susceptibility. Genome Res. 2008 May; 18(5):706-16.
      View in: PubMed
    9. Mataki C, Magnier BC, Houten SM, Annicotte JS, Argmann C, Thomas C, Overmars H, Kulik W, Metzger D, Auwerx J, Schoonjans K. Compromised intestinal lipid absorption in mice with a liver-specific deficiency of liver receptor homolog 1. Mol Cell Biol. 2007 Dec; 27(23):8330-9.
      View in: PubMed
    10. Mark M, Teletin M, Antal C, Wendling O, Auwerx J, Heikkinen S, Khetchoumian K, Argmann CA, Dgheem M. Histopathology in mouse metabolic investigations. Curr Protoc Mol Biol. 2007 Apr; Chapter 29:Unit 29B.4.
      View in: PubMed
    11. Heikkinen S, Auwerx J, Argmann CA. PPARgamma in human and mouse physiology. Biochim Biophys Acta. 2007 Aug; 1771(8):999-1013.
      View in: PubMed
    12. Heikkinen S, Argmann CA, Champy MF, Auwerx J. Evaluation of glucose homeostasis. Curr Protoc Mol Biol. 2007 Jan; Chapter 29:Unit 29B.3.
      View in: PubMed
    13. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 2006 Dec 15; 127(6):1109-22.
      View in: PubMed
    14. Argmann C, Auwerx J. Insulin secretion: SIRT4 gets in on the act. Cell. 2006 Sep 8; 126(5):837-9.
      View in: PubMed
    15. Argmann CA, Auwerx J. Collection of blood and plasma from the mouse. Curr Protoc Mol Biol. 2006 Aug; Chapter 29:Unit 29A.3.
      View in: PubMed
    16. Argmann CA, Houten SM, Champy MF, Auwerx J. Lipid and bile acid analysis. Curr Protoc Mol Biol. 2006 Aug; Chapter 29:Unit 29B.2.
      View in: PubMed
    17. Argmann CA, Champy MF, Auwerx J. Evaluation of energy homeostasis. Curr Protoc Mol Biol. 2006 Feb; Chapter 29:Unit 29B.1.
      View in: PubMed
    18. Argmann CA, Auwerx J. Minimizing variation due to genotype and environment. Curr Protoc Mol Biol. 2006 Feb; Chapter 29:Unit 29A.2.
      View in: PubMed
    19. Argmann CA, Dierich A, Auwerx J. Uses of forward and reverse genetics in mice to study gene function. Curr Protoc Mol Biol. 2006 Feb; Chapter 29:Unit 29A.1.
      View in: PubMed
    20. Argmann CA, Chambon P, Auwerx J. Mouse phenogenomics: the fast track to "systems metabolism". Cell Metab. 2005 Dec; 2(6):349-60.
      View in: PubMed
    21. Argmann CA, Edwards JY, Sawyez CG, O'Neil CH, Hegele RA, Pickering JG, Huff MW. Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux. J Biol Chem. 2005 Jun 10; 280(23):22212-21.
      View in: PubMed
    22. Argmann CA, Cock TA, Auwerx J. Peroxisome proliferator-activated receptor gamma: the more the merrier? Eur J Clin Invest. 2005 Feb; 35(2):82-92; discussion 80.
      View in: PubMed
    23. Argmann CA, Sawyez CG, Li S, Nong Z, Hegele RA, Pickering JG, Huff MW. Human smooth muscle cell subpopulations differentially accumulate cholesteryl ester when exposed to native and oxidized lipoproteins. Arterioscler Thromb Vasc Biol. 2004 Jul; 24(7):1290-6.
      View in: PubMed
    24. Rowe AH, Argmann CA, Edwards JY, Sawyez CG, Morand OH, Hegele RA, Huff MW. Enhanced synthesis of the oxysterol 24(S),25-epoxycholesterol in macrophages by inhibitors of 2,3-oxidosqualene:lanosterol cyclase: a novel mechanism for the attenuation of foam cell formation. Circ Res. 2003 Oct 17; 93(8):717-25.
      View in: PubMed
    25. Argmann CA, Sawyez CG, McNeil CJ, Hegele RA, Huff MW. Activation of peroxisome proliferator-activated receptor gamma and retinoid X receptor results in net depletion of cellular cholesteryl esters in macrophages exposed to oxidized lipoproteins. Arterioscler Thromb Vasc Biol. 2003 Mar 1; 23(3):475-82.
      View in: PubMed
    26. Argmann CA, Van Den Diepstraten CH, Sawyez CG, Edwards JY, Hegele RA, Wolfe BM, Huff MW. Transforming growth factor-beta1 inhibits macrophage cholesteryl ester accumulation induced by native and oxidized VLDL remnants. Arterioscler Thromb Vasc Biol. 2001 Dec; 21(12):2011-8.
      View in: PubMed
    27. Whitman SC, Argmann CA, Sawyez CG, Miller DB, Hegele RA, Huff MW. Uptake of type IV hypertriglyceridemic VLDL by cultured macrophages is enhanced by interferon-gamma. J Lipid Res. 1999 Jun; 40(6):1017-28.
      View in: PubMed
    Argmann's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067